Related Experiment Videos
Hypogammaglobulinaemia associated with gold therapy
Annals of the Rheumatic Diseases
|August 1, 1984
Summary
Gold treatment for seronegative arthropathy may cause hypogammaglobulinemia, a type of immunodeficiency. This suggests gold compounds can impair the immune system, requiring further investigation.
Area of Science:
- Rheumatology
- Immunology
- Pharmacology
Background:
- Seronegative arthropathy is a group of inflammatory joint diseases.
- Gold compounds have been used historically for treating rheumatoid arthritis and other inflammatory conditions.
Observation:
- Two patients with seronegative arthropathy developed hypogammaglobulinemia after gold therapy.
- The patients exhibited clinical features consistent with acquired immunodeficiency.
Findings:
- Gold administration was associated with a significant decrease in immunoglobulin levels.
- The observed hypogammaglobulinemia suggests an iatrogenic effect of gold on the immune system.
Implications:
- Gold therapy may pose a risk of inducing immunodeficiency in susceptible individuals.
- Further research is warranted to elucidate the mechanisms by which gold affects humoral immunity.
- Clinicians should consider monitoring immunoglobulin levels in patients undergoing gold treatment for inflammatory arthropathies.